Squarepoint’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-40,402
| Closed | -$127K | – | 3079 |
|
|
2020
Q3 | $127K | Sell |
40,402
-30,220
| -43% | -$95K | ﹤0.01% | 2072 |
|
|
2020
Q2 | $206K | Buy |
+70,622
| New | +$206K | ﹤0.01% | 1745 |
|
|
2020
Q1 | – | Sell |
-113,986
| Closed | -$370K | – | 2766 |
|
|
2019
Q4 | $370K | Sell |
113,986
-150,636
| -57% | -$489K | ﹤0.01% | 1870 |
|
|
2019
Q3 | $572K | Buy |
264,622
+113,602
| +75% | +$246K | 0.01% | 1492 |
|
|
2019
Q2 | $474K | Buy |
151,020
+13,286
| +10% | +$41.7K | ﹤0.01% | 1657 |
|
|
2019
Q1 | $512K | Buy |
137,734
+84,539
| +159% | +$314K | 0.01% | 1451 |
|
|
2018
Q4 | $154K | Sell |
53,195
-32,348
| -38% | -$93.6K | ﹤0.01% | 1735 |
|
|
2018
Q3 | $225K | Sell |
85,543
-74,532
| -47% | -$196K | ﹤0.01% | 1700 |
|
|
2018
Q2 | $375K | Buy |
160,075
+45,375
| +40% | +$106K | 0.01% | 1288 |
|
|
2018
Q1 | $337K | Buy |
114,700
+82,954
| +261% | +$244K | 0.01% | 1264 |
|
|
2017
Q4 | $87K | Buy |
31,746
+8,532
| +37% | +$23.4K | ﹤0.01% | 1966 |
|
|
2017
Q3 | $79K | Buy |
+23,214
| New | +$79K | ﹤0.01% | 1513 |
|
|
2017
Q1 | – | Sell |
-111,390
| Closed | -$236K | – | 2200 |
|
|
2016
Q4 | $236K | Buy |
111,390
+90,590
| +436% | +$192K | 0.01% | 1312 |
|
|
2016
Q3 | $70K | Buy |
+20,800
| New | +$70K | ﹤0.01% | 969 |
|
|
2016
Q1 | – | Sell |
-49,000
| Closed | -$173K | – | 1690 |
|
|
2015
Q4 | $173K | Buy |
+49,000
| New | +$173K | 0.02% | 1036 |
|